EPISODE · Aug 1, 2025 · 10 MIN
A Focus on Rebalancing Agents
from Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies · host Annenberg Center for Health Sciences
Abstract 1: Association of antithrombin levels with efficacy of fitusiran prophylaxis in people with hemophilia A or B with and without inhibitors: a predictive modeling approachAbstract 2: Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 studyAbstract 3: Long-term efficacy of marstacimab in participants with severe hemophilia A or B without inhibitors
What this episode covers
Abstract 1: Association of antithrombin levels with efficacy of fitusiran prophylaxis in people with hemophilia A or B with and without inhibitors: a predictive modeling approachAbstract 2: Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 studyAbstract 3: Long-term efficacy of marstacimab in participants with severe hemophilia A or B without inhibitors
NOW PLAYING
A Focus on Rebalancing Agents
No transcript for this episode yet
Similar Episodes
Apr 22, 2025 ·32m
Feb 27, 2025 ·0m
Sep 20, 2024 ·57m
Aug 7, 2024 ·16m